Open access · CC-BY
via OpenAlex
DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age
Ha‐Neui Kim, Jianhui Chang, Lijian Shao, Li Han, Srividhya V. Iyer, Stavros C. Manolagas, Charles A. O’Brien, Robert L. Jilka, Daohong Zhou, Maria Almeida
Aging Cell · 2017 · ▲ 194 citations
Genomic instability
Cellular senescence
Stem-cell exhaustion
Chronic inflammation
Senolytics
Cell culture / in vitro
Mouse
In vitro
Abstract
Summary Age‐related bone loss in mice results from a decrease in bone formation and an increase in cortical bone resorption. The former is accounted by a decrease in the number of postmitotic osteoblasts which synthesize the bone matrix and is thought to be the consequence of age‐dependent changes in mesenchymal osteoblast progenitors. However, there are no specific markers for these progenitors, and conclusions rely on results from in vitro cultures of mixed cell populations. Moreover, the culprits of such changes remain unknown. Here, we have used Osx1‐Cre;TdRFP mice in which osteoprogenitors express the TdRFP fluorescent protein. We report that the number of TdRFP‐Osx1 cells, freshly isolated from the bone marrow, declines by more than 50% between 6 and 24 months of age in both female and male mice. Moreover, TdRFP‐Osx1 cells from old mice exhibited markers of DNA damage and senescence(definition), such as γH2AX foci, G1 cell cycle arrest, phosphorylation of p53, increased p21CIP1 levels, as well as increased levels of GATA4 and activation of NF‐κB – two major stimulators of the senescence‐associated secretory phenotype (SASP). Bone marrow stromal cells from old mice also exhibited elevated expression of SASP genes, including several pro‐osteoclastogenic cytokines, and increased capacity to support osteoclast formation. These changes were greatly attenuated by the senolytic drug ABT263. Together, these findings suggest that the decline in bone mass with age is the result of intrinsic defects in osteoprogenitor cells, leading to decreased osteoblast numbers and increased support of osteoclast formation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.12597
- Canonical
- link ↗
- Fetched
- 2026-09-26 MST
Cite this
APA
Kim, H., Chang, J., Shao, L., Han, L., Iyer, S.V., Manolagas, S.C., O’Brien, C.A., Jilka, R.L., Zhou, D., & Almeida, M. (2017). DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age. <em>Aging Cell</em>. https://doi.org/10.1111/acel.12597
Vancouver
Kim H, Chang J, Shao L, Han L, Iyer SV, Manolagas SC, et al. DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age. Aging Cell. 2017. doi:10.1111/acel.12597.
BibTeX
@article{haneui2017DNAdam,
title = {DNA damage and senescence in osteoprogenitors expressing Osx1 may cause their decrease with age},
author = {Ha‐Neui Kim and Jianhui Chang and Lijian Shao and Li Han and Srividhya V. Iyer and Stavros C. Manolagas and Charles A. O’Brien and Robert L. Jilka and Daohong Zhou and Maria Almeida},
journal = {Aging Cell},
year = {2017},
doi = {10.1111/acel.12597},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2026
Open access · CC-BY
Cell Type‐Specific Expression of p16, p21, and p53 Reveals Age‐Dependent Glial Senescence in the App NL‐G‐F Mouse Model of Alzheimer's Disease
npj Aging and Mechanisms of Disease 2021
Open access · CC-BY
A decrease in NAD+ contributes to the loss of osteoprogenitors and bone mass with aging
Annals of Hematology 2012
Citation only
Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells
Stem Cells 2009
Open access · OA
MicroRNA-204 Regulates Runx2 Protein Expression and Mesenchymal Progenitor Cell Differentiation
European Heart Journal 2019
Citation only
P6296The role of extracellular matrix protein 1 (ECM1) - a novel link between inflammation and cardiac fibrosis
Stem Cell Research & Therapy 2025
Open access · CC-BY